- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1, NEJM 2022, n=2,539) FDA Prescribing Information - semaglutide (weekly injection, chronic weight management) FDA Prescribing Information - tirzepatide (weekly injection, chronic weight management) FDA - Medication Guides and prescribing information database (Drugs@FDA) Comparison sources MeAgain App Store listing (verified June 11, 2026) MeAgain Google Play listing (verified June 11, 2026) Shotsy App Store listing Shotsy Google Play listing Glapp App Store listing Pep App Store listing Pep Google Play listing Phaze App Store listing Phaze Google Play listing MyFitnessPal App Store listing MyFitnessPal Google Play listing Cronometer App Store listing Cronometer Google Play listing What GLP-1 Users Say After Trying Multiple Tracker Apps 4.8 out of 5 from 25K App Store ratings and the recurring theme in MeAgain reviews is comparison: people arrive after trying other trackers

\Visual Improvement: 90% positive response in retinitis pigmentosa (Human Study)
You do not need to rely on someone else to inject for you
Adv Exp Med Biol 247A:8796 Simon-Friedt BR, Wilson MJ, Blake DA, Yu H, Eriksson Y, Wickliffe JK (2015) The RPTEC/TERT1 cell line as an improved tool for in vitro nephrotoxicity assessments
Alogliptin for the treatment of type 2 diabetes